Schrodinger, Inc. — Investor Relations & Filings

Schrödinger is a scientific leader providing a physics-based computational platform to accelerate the discovery of novel molecules for therapeutics and materials. The company operates through two segments: Software and Drug Discovery. The Software segment licenses its advanced molecular simulation platform to biopharmaceutical, industrial, and academic organizations, enabling scientists to design and optimize molecules with greater precision. The Drug Discovery segment leverages this proprietary platform to advance a pipeline of collaborative and wholly-owned therapeutic programs. By integrating physics-based modeling with machine learning, Schrödinger's technology aims to transform molecular design, with a mission to improve human health and quality of life.